Navigation Links
Men Might Get Their Share of Cervical Cancer Vaccine As Well

The first ever-cervical cancer vaccine, Gardasil is expected to be launched in New Zealand soon, targeting females between 9 and 24 years of age. // Soon, men might also be given cervical cancer vaccines to prevent them from infecting their sexual partners and to protect themselves against several diseases.

The vaccine is currently under experimental phase, for demonstration of cervical cancer prevention. Most cases of cervical cancer can be attributed to human papilloma virus infection (HPV), spread through sexual contact. An association between the virus and anal cancer has also been observed, consistent with high reports of infection among gay men.

Previous vaccine trials had demonstrated the increase in antibody production against the four target HPV types, known to cause cancer and genital warts in both men and women. There could be a 70% reduction in the cervical cancer incidence if the vaccine is found to be effective in preventing HPV associated cervical cancers.

It has been found form numerous studies that 80% of the population is exposed to HPV at some point during their lifetime. A majority of this goes unnoticed, as there are no symptoms. The immune system may be effective in getting rid of the virus. A small group of people however develop persistent infections.

The effectiveness of the vaccine would be more relevant when it is administered before onset of sexual activity. Taking this fact into account, the ideal age for administration of the vaccine is considered to be 11 years. If approved for use, it can be incorporated as the last of injections on the national immunization schedule.

Cervical cancer represents a major health care burden haunting women. This may be the focus for increased clinical trials in women when compared to the poor attention given to prevention of HPV-linked cancers in men. However, large clinical trials involving men are being conducted, the results of which would be released in three years time.

In line with these clinical trials, GlaxoSmithKline is also testing a potential HPV vaccine. With such healthy competition among several pharmaceutical companies, we might perhaps soon put an end to the misery and suffering associated with at least one form of cancer.


Related medicine news :

1. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
2. Tomatoes Might Inhibit the Development Of Prostate Cancer
3. Mad Cow Disease Might Be Linked to Blood Transfusions
4. Strategies That Might Lower Blood Pressure Questioned
5. Factors That Might Increase The Risk Of Schizophrenia
6. A Drug That Might Relieve Chronic Cough
7. Biochemical Markers Might Help Predict Heart Problems
8. Yoga Might Be Helpful For Cancer Patients
9. Healthcare Professionals Might Want To Rethink Their Dress Code
10. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
11. Counting Calories Might Be The Ideal Way To Stay Healthy
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... Trustify is proud to announce the success ... Becky’s Fund, an organization dedicated to ending domestic violence. , Trustify and Becky’s Fund ... victims and survivors of domestic violence. Trustify is also proud to announce the launch ...
(Date:12/1/2015)... ... December 01, 2015 , ... World Patent Marketing , ... a container patent that allows for easier packing and organizing of items into one ... $90 billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing and ...
(Date:12/1/2015)... ... December 01, 2015 , ... Integrated Rental Services ... Jordan Industries International, LLC (“JII”). , With support from JII, Integrated Rental is ... to hospitals, surgery centers, clinics, research labs and medical facilities across the United ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... of leadless pacemakers in the U.S. and is the only hospital in the ... the largest clinical data presentation of transcatheter pacing patients were revealed recently at ...
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation claim ... of hospital and nonhospital care, according to a recent study by the Workers Compensation ... Edition , found medical payments per claim with more than seven days of lost ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 --> ... Drugs Market by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, ... and Pipeline Analysis - Global Forecast to 2020", published by ... USD 73,529.2 Million by 2020 from USD 40,281.6 Million in ... Browse 37 market data ...
(Date:12/1/2015)... BANGALORE, India and ... (NASDAQ, TASE: MYL) today announced that it expects to ... for developing country markets funded by international donors, TLE400 ... + Efavirenz 400 mg) for $99 per patient, per ... (CHAI) to develop TLE400. The significantly reduced price could ...
(Date:12/1/2015)... 1, 2015  AccuTEC Blades, a leader in ... logo and brand identity program. The new logo ... of bladed products where "the edge makes all ... --> Serving manufacturers and distributors of medical, ... equipment, AccuTEC,s product lines include those acquired when ...
Breaking Medicine Technology: